CD47 and neoplasm: ,59 Considering that limited synergy was observed when CD47 and PD-L1 blockades were combined here, additional tumor-intrinsic characteristics, such as production of anti-inflammatory cytokines, loss of antigen expression, or the presence of immunosuppressive cell types, may further limit the efficacy of anti-tumor immune responses.60